Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 8:16 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 985–1008 of 1,144 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Grippe Clear all

Conditions: Influenza
Interventions: Influenza VLP Vaccine, TIV; Biological
Lead sponsor: Novavax; Industry
Eligibility: 60 Years and older
Enrollment: 467 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 6
States / cities: Pembroke Pines, Florida • Rochester, Minnesota • Providence, Rhode Island + 3 more

Conditions: Pediatric Solid Organ Transplant Patients
Interventions: High-Dose trivalent inactivated influenza vaccine, Standard dose trivalent inactivated influenza vaccine; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 3 Years to 17 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Influenza
Interventions: Not listed
Lead sponsor: QIAGEN Gaithersburg, Inc; Industry
Eligibility: Not listed
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 3
States / cities: Tucson, Arizona • Chapel Hill, North Carolina • Columbus, Ohio

Conditions: Influenza
Interventions: Flublok Quadrivalent Influenza Vaccine, Inactivated Influenza Vaccine; Biological
Lead sponsor: Protein Sciences Corporation; Industry
Eligibility: 50 Years and older
Enrollment: 9,003 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 38
States / cities: Mobile, Alabama • Tempe, Arizona • Little Rock, Arkansas + 34 more

Conditions: Influenza
Interventions: VAX2012Q; Biological
Lead sponsor: VaxInnate Corporation; Industry
Eligibility: 18 Years to 40 Years
Enrollment: 316 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 4
States / cities: Lenexa, Kansas • Rochester, New York • Mt. Pleasant, South Carolina + 1 more

Conditions: Colorectal Cancer Screening
Interventions: FLU-FIT Program; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 50 Years to 75 Years
Enrollment: 7,465 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Oakland, California

Conditions: Influenza Vaccination
Interventions: Question (Q), Messaging (M); Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 776 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 8
States / cities: San Francisco, California • Durham, North Carolina • Philadelphia, Pennsylvania + 2 more

Conditions: Influenza
Interventions: GSK A/turkey H5N1 Influenza vaccine; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 469 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 7
States / cities: Huntsville, Alabama • Anaheim, California • Miami, Florida + 4 more

Conditions: Influenza, Orthomyxoviridae Infections
Interventions: Influenza Virus Vaccine No Preservative: Pediatric Dose; Biological
Lead sponsor: Sanofi Pasteur, a Sanofi Company; Industry
Eligibility: 6 Months to 5 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Behavior, Health, Flu, Flu Vaccination
Interventions: Pre-visit patient text messaging, Default pended order, Monthly peer comparison feedback, High risk bidirectional pre-visit text messaging; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 50 Years and older
Enrollment: 80,039 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania • Seattle, Washington

Conditions: Influenza, Virus Diseases
Interventions: H5N1 (6-2) AA ca Recombinant (A/Hong Kong/213/2003 x A/AnnArbor/6/60 ca); Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 49 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Influenza, Virus
Interventions: Not listed
Lead sponsor: Scripps Translational Science Institute; Other
Eligibility: 18 Years and older
Enrollment: 100,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: San Diego, California

Conditions: Influenza, Healthy
Interventions: Fluzone®, FluMist®; Biological
Lead sponsor: Stanford University; Other
Eligibility: 6 Months to 10 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Stanford, California

Conditions: Influenza
Interventions: Oseltamivir Phosphate, ADS-8902; Drug
Lead sponsor: Adamas Pharmaceuticals, Inc.; Industry
Eligibility: 1 Year to 65 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 16
States / cities: San Francisco, California • Hollywood, Florida • Miramar, Florida + 11 more

Conditions: Healthy Volunteers, Influenza
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years and older
Enrollment: 203 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2009
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Influenza
Interventions: Fluzone: Influenza virus vaccine; Biological
Lead sponsor: Sanofi Pasteur, a Sanofi Company; Industry
Eligibility: 18 Years to 49 Years
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 2
States / cities: Grove City, Pennsylvania • Pittsburgh, Pennsylvania

Conditions: Influenza
Interventions: Trivalent Inactivated Influenza Vaccine; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 6 Months to 35 Months
Enrollment: 243 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 7
States / cities: Atlanta, Georgia • Iowa City, Iowa • Baltimore, Maryland + 3 more

Conditions: Respiratory Pathogens, Upper Respiratory Tract Illness, Lower Respiratory Tract Illness, Acute Respiratory Infection
Interventions: Results available to provider; Diagnostic Test
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 1 Month to 18 Years
Enrollment: 913 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Influenza
Interventions: Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur); Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Influenza Vaccine
Interventions: TIV, Trivalent Inactivated Influenza Virus Vaccine, FluMist, Influenza Virus Vaccine Live; Biological
Lead sponsor: MedImmune LLC; Industry
Eligibility: 12 Months to 35 Months
Enrollment: 101 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 19
States / cities: Jonesboro, Arkansas • Little Rock, Arkansas • Anaheim, California + 16 more

Conditions: Influenza Like Illness, Asthma, Group A Streptococcal Infection, Pertussis
Interventions: What's Going Around tool, Control; Other
Lead sponsor: Endeavor Health; Other
Eligibility: Not listed
Enrollment: 206,703 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Influenza
Interventions: High-Dose trivalent influenza vaccine (Split virion, Inactivated), Standard-dose trivalent influenza vaccine (Split virion, Inactivated); Biological
Lead sponsor: Sanofi Pasteur, a Sanofi Company; Industry
Eligibility: 50 Years to 64 Years
Enrollment: 1,180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 20
States / cities: Los Alamitos, California • Fort Myers, Florida • Hollywood, Florida + 16 more

Conditions: Viral Infections, Respiratory Infections
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 2 Years and older
Enrollment: 137 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Seasonal Influenza Preventative Vaccine Pharmacodynamics
Interventions: VXA-A1.1 H1 Tablet Vaccine (small), VXA-A1.1 H1 Tablet Vaccine (large); Biological
Lead sponsor: Vaxart; Industry
Eligibility: 18 Years to 49 Years · Male only
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Lexington, Kentucky

Search by objective public record fields.

Evaluate the Safety and Immunogenicity of a Seasonal Influenza Virus-Like Particle (VLP) Vaccine in Older Adults

Standard Dose Versus High-Dose Inactivated Flu Vaccine in Pediatric Solid Organ Transplant Patients

Collection and Extraction of Respiratory Specimens

Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age

Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention

FLU-FIT Program at Kaiser Permanente Northern California

PROmotion of FLU Vaccine Uptake in the Emergency Department - PROFLUVAXED

Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years

Annual Study for Serum Collection for Immunogenicity and Safety Evaluation in Healthy Children Receiving Fluzone®

Behavioral Economics to Improve Flu Vaccination Using EHR Nudges

Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

The DETECT(Digital Engagement & Tracking for Early Control, & Treatment) Study

The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection

Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects

Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines

Study to Determine a Preference for Fluzone Vaccine Given Intradermally (ID) and Intramuscularly (IM) in Healthy Adults

Comparison of Flu Vaccine Doses in Children

The RAPID Trial: Assessing Point-of-care Influenza and Other Respiratory Virus Diagnostics

St. Jude Open Label H5 Trial

A Phase 2 Study to Evaluate Immune Responses of FluMist®

How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice

Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of Age

Influenza in People With Normal and Weakened Immune Systems

Pharmacodynamic Open-Label Trial With VXA-A1.1 Oral H1 Vaccine in Healthy Adults